BiotechTube
Home/Medivir/Fredrik Öberg
FÖ

Fredrik Öberg

Chief Medical Officer (CMO)

Medivir

Therapeutic Areas

OncologyLiver Cancer

Medivir Pipeline

DrugIndicationPhase
Fostroxacitabine bralpamide (MIV-818)Hepatocellular Carcinoma (HCC)Phase 2a
Protease Inhibitor Discovery ProgramsOncology (Undisclosed)Discovery
Nucleoside/Nucleotide Discovery ProgramsOncology (Undisclosed)Discovery

Leadership Team at Medivir

JL
Jens Lindberg
Chief Executive Officer (CEO)
PS
Pernilla Sandwall
Chief Financial Officer & Head of Operations (CFO)
UH
Uli Hacksell
Chairman of the Board
View full Medivir profile